"COVID-19 Drug Treatment"[MAJR] - Search Results

Year	Number of Results
2020	1644
2021	4078
2022	3640
2023	129
2024	363

1

Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis.

Lee TC, Murthy S, Del Corpo O, Senécal J, Butler-Laporte G, Sohani ZN, Brophy JM, McDonald EG. Lee TC, et al. Clin Microbiol Infect. 2022 Sep;28(9):1203-1210. doi: 10.1016/j.cmi.2022.04.018. Epub 2022 May 19. Clin Microbiol Infect. 2022. PMID: 35598856 Free PMC article. Review.

2

Vitamin C Supplementation for the Treatment of COVID-19: A Systematic Review and Meta-Analysis.

Olczak-Pruc M, Swieczkowski D, Ladny JR, Pruc M, Juarez-Vela R, Rafique Z, Peacock FW, Szarpak L. Olczak-Pruc M, et al. Nutrients. 2022 Oct 10;14(19):4217. doi: 10.3390/nu14194217. Nutrients. 2022. PMID: 36235869 Free PMC article.

3

Pharmacology of COVID-19.

Sureda A, Habtemariam S, Nabavi SM. Sureda A, et al. Chem Biol Interact. 2022 Aug 1;362:110005. doi: 10.1016/j.cbi.2022.110005. Epub 2022 May 31. Chem Biol Interact. 2022. PMID: 35662545 Free PMC article. No abstract available.

4

Niclosamide-A promising treatment for COVID-19.

Singh S, Weiss A, Goodman J, Fisk M, Kulkarni S, Lu I, Gray J, Smith R, Sommer M, Cheriyan J. Singh S, et al. Br J Pharmacol. 2022 Jul;179(13):3250-3267. doi: 10.1111/bph.15843. Epub 2022 Apr 11. Br J Pharmacol. 2022. PMID: 35348204 Free PMC article. Review.

5

Molnupiravir for the treatment of COVID-19.

Santani BG, LeBlanc BW, Thakare RP. Santani BG, et al. Drugs Today (Barc). 2022 Jul;58(7):335-350. doi: 10.1358/dot.2022.58.7.3419558. Drugs Today (Barc). 2022. PMID: 35851869

6

Antiviral drug treatment for nonsevere COVID-19: a systematic review and network meta-analysis.

Pitre T, Van Alstine R, Chick G, Leung G, Mikhail D, Cusano E, Khalid F, Zeraatkar D. Pitre T, et al. CMAJ. 2022 Jul 25;194(28):E969-E980. doi: 10.1503/cmaj.220471. CMAJ. 2022. PMID: 35878897 Free PMC article.

7

Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?

Chhatwal J, Basu A. Chhatwal J, et al. Value Health. 2022 May;25(5):697-698. doi: 10.1016/j.jval.2022.02.002. Epub 2022 Mar 19. Value Health. 2022. PMID: 35315330 Free PMC article. No abstract available.

8

RT-PCR negative COVID-19.

Parmar H, Montovano M, Banada P, Pentakota SR, Shiau S, Ma Z, Saibire K, Chopoorian A, O'Shaughnessy M, Hirsch M, Jain P, Demirdjian G, Karagueuzian M, Robin T, Salvati M, Patel B, Alland D, Xie YL. Parmar H, et al. BMC Infect Dis. 2022 Feb 13;22(1):149. doi: 10.1186/s12879-022-07095-x. BMC Infect Dis. 2022. PMID: 35152885 Free PMC article.

9

Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment.

Taibe NS, Kord MA, Badawy MA, Shytaj IL, Elhefnawi MM. Taibe NS, et al. Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221132736. doi: 10.1177/17534666221132736. Ther Adv Respir Dis. 2022. PMID: 36282077 Free PMC article. Review.

10

[Treatment of COVID-19].

Yatera K. Yatera K. Nihon Yakurigaku Zasshi. 2022;157(4):214-220. doi: 10.1254/fpj.22019. Nihon Yakurigaku Zasshi. 2022. PMID: 35781447 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8,444 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8,444 results

Results by year